ArticleScientific reports2025

Rapid and sustainable deep testosterone reduction predicts effective androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Ze Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.